GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1 ... interest in these ...
Hims & Hers (NYSE:HIMS) has launched an online GLP-1 supply tracker where people can share information about where the ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 ...